Differences between graft product and donor side effects following bone marrow or stem cell donation
BONE MARROW TRANSPLANTATION, vol.32, no.9, pp.873-880, 2003 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 32 Issue: 9
- Publication Date: 2003
- Doi Number: 10.1038/sj.bmt.1704245
- Journal Name: BONE MARROW TRANSPLANTATION
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.873-880
- Keywords: allogeneic hematopoietic stem cell transplantation, peripheral blood stem cells, granulocyte colony-stimulating factor, leukapheresis, donor safety, PERIPHERAL-BLOOD STEM, COLONY-STIMULATING FACTOR, PROGENITOR-CELL, ALLOGENEIC TRANSPLANTATION, RANDOMIZED-TRIAL, EUROPEAN-GROUP, MOBILIZATION, LEUKEMIA, EXPERIENCE, FILGRASTIM
- Open Archive Collection: AVESIS Open Access Collection
- Ankara University Affiliated: Yes
Abstract
We report graft product stem cell yields and donor safety results of a randomized multicenter study comparing allogeneic peripheral blood stem cell (PBSC) PBSC transplantation with BM trans plantation. Matched HLA-identical sibling donors (n = 329) were randomized to filgrastim-mobilized PBSC or bone marrow (BM) donation groups. Median yields per kg recipient weight of CD34(+) cells, T cells, and natural killer (NK) cells, respectively, were approximately two-fold, eight-fold, and greater than eight-fold in the PBSC group than in the BM group (CD34(+) cells, 5.8 x 10(6)/kg vs 2.7 x 10(6)/kg; T cells, 300.1 x 10(6)/kg vs 35.7 x 10(6)/kg; NK cells, 28.2 x 10(6)/kg vs 3.6 x 10(6)/kg; P < 0.001 for each). In connection with the cell collection procedures, PBSC donors spent a shorter median time in hospital than BM donors (0 vs 2 days; median difference -2 days, 95% CI -2 to 2) and had fewer median days of restricted activity (2 vs 6 days; median difference -3 days, 95% CI -4 to 2). Overall, 65% of PBSC donors and 57% of BM donors reported at least one adverse event (AE), most of which were transient, mild-moderate in severity, and without clinical sequelae. PBSC donors experienced predominantly filgrastim-related AEs, while BM donors experienced predominantly harvest-related AEs.